Celldex Therapeutics (CLDX) Enterprise Value (2010 - 2026)
Celldex Therapeutics' Enterprise Value was $2.2 billion in Q2 2026, up 205.7% from $720.79 million a year earlier and up 32.7% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Enterprise Value (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Celldex Therapeutics' Enterprise Value was $650.15 million through Jun 30, 2026; for FY2025, it was $1.29 billion, up 35.4% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of 31.7% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $952 million in FY2024 (-46.9%), $1.79 billion in FY2023 (-0.3%), $1.8 billion in FY2022 (+28.7%) and $1.4 billion in FY2021 (+330.1%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value since Q1 2015.
- Compared with a year earlier, Enterprise Value has increased for three straight quarters, with growth averaging 36.7% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q3 2021 (growth of 441.5%); the worst was Q1 2025 (a decline of 72.6%).
- Per Business Quant data, CLDX's Enterprise Value in the three quarters before Q2 2026 was $1.66 billion (Q1 2026), $1.29 billion (Q4 2025) and $1.14 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.20 Bn |
| Mar 31, 2026 | 1.66 Bn |
| Dec 31, 2025 | 1.29 Bn |
| Sep 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 720.79 Mn |
| Mar 31, 2025 | 531.58 Mn |
| Dec 31, 2024 | 952.00 Mn |
| Sep 30, 2024 | 1.50 Bn |
| Jun 30, 2024 | 1.65 Bn |
| Mar 31, 2024 | 1.94 Bn |
| Dec 31, 2023 | 1.79 Bn |
| Sep 30, 2023 | 1.07 Bn |
| Jun 30, 2023 | 1.35 Bn |
| Mar 31, 2023 | 1.42 Bn |
| Dec 31, 2022 | 1.80 Bn |
| Sep 30, 2022 | 1.00 Bn |
| Jun 30, 2022 | 903.96 Mn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.40 Bn |
| Sep 30, 2021 | 2.10 Bn |
API Access
Celldex Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();